Announcements Trials
Browse Landscape

Status

Recruiting 8Completed 7Not yet recruiting 3Active not recruiting 1

Sponsor Class

INDUSTRY 5OTHER 2

Study Type

Interventional 17Observational 7

Sponsor

Cancer Type

Genitourinary 7

Conditions

Prostatic Neoplasms 2Non-metastatic Castration-resistant Prostate Cancer 2Non-metastatic Prostate Cancer 1Metastatic Hormone-sensitive Prostate Cancer 1Advanced Prostate Carcinoma 1

Interventions

Surveys and Questionnaires 286Blood Specimen Collection 145Gene Expression Profiling 96Interviews as Topic 83Immunohistochemistry 78Polymerase Chain Reaction 64Surgical Procedures, Operative 62Magnetic Resonance Spectroscopy 58Microarray Analysis 55Flow Cytometry 53Radiotherapy 49Amplified Fragment Length Polymorphism Analysis 48Drug Therapy 46Observation 45Biopsy 42Reverse Transcriptase Polymerase Chain Reaction 39Bevacizumab 39Data Collection 35Sorafenib 29Psychiatric Rehabilitation 29Nivolumab 28palbociclib 26In Situ Hybridization, Fluorescence 26Rituximab 25Therapeutics 24Neoadjuvant Therapy 24Hepatectomy 24Docetaxel 24Colonoscopy 24Sunitinib 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Completed × Observational × darolutamide × Clear all
NCT07428642 2026-03-18

PSMA PET/CT-Based Multimodal Model for Predicting Response to First-Line Therapy in mHSPC.

First Affiliated Hospital of Wenzhou Medical University

Completed
168 enrolled
Genitourinary

Prostatic Neoplasms

NCT05202301 2025-08-11

A Study Using Available Data to Learn to What Extent Patients With Prostate Cancer Who Received Second Generation Androgen Receptor Inhibitors Took Their Medication as Prescribed or Stopped Taking Their Medication Completely

Bayer

Completed
13,779 enrolled
Genitourinary

Prostatic Neoplasms

NCT06013475 2025-06-12

DEAR-EXT

Bayer

Completed
1,375 enrolled
Genitourinary

Non-metastatic Castration-resistant Prostate Cancer

NCT05612880 2025-01-09

Physical Function During ARSI Treatment

UNC Lineberger Comprehensive Cancer Center

Completed
24 enrolled
Genitourinary

Advanced Prostate Carcinoma

NCT06498921 2024-10-24

BELBEQA

Bayer

Completed
106 enrolled
Genitourinary

Metastatic Hormone-sensitive Prostate Cancer

NCT06204302 2024-04-09

ARENA

Bayer

Completed
1,800 enrolled
Genitourinary

Non-metastatic Prostate Cancer

NCT05362149 2024-03-20

DEAR

Bayer

Completed
870 enrolled
Genitourinary

Non-metastatic Castration-resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡